Skip to main content

Korro Bio, Inc.

KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001703647

In the last 90 days, Korro Bio, Inc. insiders filed 1 open-market purchase and 7 sales; 106 institutions reported holding it in 13F filings for Q2 2026, worth $190.1M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Korro Bio, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of KRRO: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders92183−8
Shares9.76M368.1K7.56M−1.83M (−19.5%)
Value$465.5M$17.6M$60.6M−$387.3M (−86.5%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Korro Bio, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to KRRO in Q4 2025
InstitutionSharesValue% of portfolio
Lynx1 Capital Management LP677,915$5.43M1.10%
Nantahala Capital Management, LLC600,000$4.81M0.29%
Jane Street Group, LLC288,457$2.31M0.00%
Susquehanna International Group, LLP196,827$1.58M0.00%
Graham Capital Management, L.P.40,766$326.5K0.01%
Acadian Asset Management LLC33,790$270.0K0.00%
AIHC Capital Management Ltd30,265$242.4K0.23%
Simplex Trading, LLC28,247$226.3K0.01%
Quadrature Capital Ltd27,064$216.8K0.00%
Engineers Gate Manager LP26,885$215.3K0.00%
Marshall Wace, LLP19,772$158.4K0.00%
Jain Global LLC10,574$84.7K0.00%
Guggenheim Capital LLC10,439$83.6K0.00%
Group One Trading, L.P.4,000$32.0K0.00%
TD Waterhouse Canada Inc.800$6.40K0.00%
Federated Hermes, Inc.302$2.42K0.00%
UBS Asset Management Americas Inc91$7290.00%
Keating Financial Advisory Services, Inc.63$5050.00%
Global Retirement Partners, LLC35$2800.00%
Rothschild Investment LLC6$480.00%
Sunbelt Securities, Inc.1$80.00%
Los Angeles Capital Management LLC110––

Sold out (30)

Institutions that held Korro Bio, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (1)

Institutions that held Korro Bio, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KRRO in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Qiming U.S. Ventures Management, LLC368,085$17.6M